Motus GI, C4 Therapeutics among healthcare movers

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
Nephros Announces Financial Results for Quarter Ended September 30, 2024
Nephros Schedules Third Quarter 2024 Financial Results Conference Call
Nephros Launches New HydraGuard 20" UltraFilter
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton
Nephros Announces Financial Results for Quarter Ended June 30, 2024
Nephros Schedules Second Quarter 2024 Financial Results Conference Call
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.